MarketingSherpa’s tenth annual MarketingSherpthe only email marketing conference based on proven research and science, will be held February 19-22 at the Paris Las Vegas Hotel & Casino.
Four power-packed days of hands-on training includes 25 speakers, 30 roundtable discussions and eight breakout sessions. Five tactical trainings will focus on optimizing email marketing programs, and leveraging analytics and testing to gauge results and return on investment.
To view Multimedia News Release, go to http://www.multivu.com/players/English/59419-meclabs-email-summit-2013/
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced the expansion of Emdeon Clinical Exchange™, its technology-enabled solution designed to improve business and clinical outcomes and care continuity.
Emdeon Clinical Exchange encompasses products and services that are designed to unite healthcare communities. Today, hospitals, physicians, labs, payers and pharmacies use Emdeon’s leading healthcare information network to securely exchange health information over six billion times annually. These healthcare stakeholders are demanding greater connectivity to each other and the ability to facilitate comprehensive, end-to-end clinical information exchange.
To view Multimedia News Release, go to http://www.multivu.com/mnr/48120-emdeon-expands-clinical-information-exchange-capabilities
Texas Instruments Incorporated (TI) (NASDAQ: TXN) today introduced TI Silicon Valley Labs, its research center for innovation in analog and mixed signal electronics. The labs’ charter is to conduct advanced research and development in analog and mixed signal circuits and technologies through recruitment of top talent and close collaboration with universities and customers. Watch a video about TI Silicon Valley Labs at http://www.ti.com/analogresearch-prv.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54043-texas-instruments-ti-silicon-valley-labs-analog-mixed-signal-electronics
Miramar Labs today announced that the miraDry System for the treatment of primary axillary hyperhidrosis, commonly known as excessive underarm sweat, is now available to select physicians in the U.S. The miraDry procedure provides a safe and lasting solution for this debilitating condition.
The U.S. Food & Drug Administration granted clearance for miraDry following a robust, randomized, blinded clinical study that involved 120 patients at seven clinics and followed them 12-months post treatment. The miraDry System delivers energy non-invasively to the area under the arm where the sweat glands reside which creates localized heat to destroy and eliminate the glands. Since sweat glands do not regenerate, results are lasting.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54021-miramar-labs-miradry-treat-excessive-underarm-sweat-axillary-hyperhidrosis
Bluefin Labs (www.bluefinlabs.com) unveiled technology today to discover and analyze what people say via social media about the shows and ads they watch on television in real time. The technology, currently in pilot with several global brands, agencies and media companies, lets marketers see audience response to mass media, providing insight to develop measurably more targeted and responsive campaigns.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bluefinlabs/48357/